Search Results for ''

published presentations and documents on DocSlides.

Eribulin Mesylate + Trastuzumab

Eribulin Mesylate + Trastuzumab

by easyho

as First-Line Therapy for Locally Recurrent or . M...

Breast Cancer in Older Patients

Breast Cancer in Older Patients

by ButterflyKisses

Key Issues. Etienne GC . Brain. , MD . PhD. Instit...

by danika-pritchard

patients . i.e. Patient relapses during or within...

Metastatic HER2-Positive Breast Cancer: Treatment Selection

Metastatic HER2-Positive Breast Cancer: Treatment Selection

by test

First . Line and Beyond. Moderator:. Joseph Gligo...

by tawny-fly

Gradishar. . MD, FACP. Betsy . Bramsen. Profess...

Neoadjuvant Target Therapy in Her-2 Positive Breast Cancer

Neoadjuvant Target Therapy in Her-2 Positive Breast Cancer

by faustina-dinatale

Dr. . Khaled Abulkhair, PhD. Medical Oncology SCE...

Budget impact and cost-effectiveness of oncology

Budget impact and cost-effectiveness of oncology

by roxanne

biosimilars. Prof. dr. Steven Simoens. Health econ...

Cost Impact Of Biosimiliars in Oncology

Cost Impact Of Biosimiliars in Oncology

by williams

Mansoor A Khan, BS, MS, BCOP. Senior Clinical Phar...

Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use

Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use

by gelbero

Sara A. Hurvitz, MD, FACP. Professor of Medicine. ...

Risk of Heart Failure in Breast Cancer Patients After

Risk of Heart Failure in Breast Cancer Patients After

by sophia2

Anthracycline. and . Trastuzumab. Treatment: A R...

Module 9: HER2-Positive and Triple-Negative BC

Module 9: HER2-Positive and Triple-Negative BC

by unita

Percent with Patients. Number of Patients (Median)...

Mauricio Lema Medina – Clínica de Oncología Astorga / Clínica SOMA, Medellín

Mauricio Lema Medina – Clínica de Oncología Astorga / Clínica SOMA, Medellín

by delcy

Trastuzumab-emtansine. : A . very. . nice. . poi...

Antibody–Drug Conjugates in Development for Non-

Antibody–Drug Conjugates in Development for Non-

by elizabeth

s. mall Cell . Lung Cancer. , Gastric Cancer, and ...

HER2 positive breast carcinoma in the pre and post adjuvant anti-HER-2 therapy era: a single academ

HER2 positive breast carcinoma in the pre and post adjuvant anti-HER-2 therapy era: a single academ

by carny

Heather M. Gage, MD, Avanti . Rangnekar. , Robert ...

update in metastatic breast c

update in metastatic breast c

by min-jolicoeur

. Dr.Mina. . Tajvidi. Radiation . oncologist. ...

Metastatic triple-positive

Metastatic triple-positive

by marcos147

breast. . cancer. . needs. . different. . ther...

Antibody–Drug Conjugates

Antibody–Drug Conjugates

by wang

in Development for . Breast Cancer. Sara A. Hurvit...

Dawid Sigorski, Ph.D .

Dawid Sigorski, Ph.D .

by morgan

Department. of . oncology. . UWM. Epidemiology. ...

Systemic Therapy for Breast Cancer

Systemic Therapy for Breast Cancer

by natalia-silvester

Adjuvant or Neoadjuvant. Agustin A Garcia, MD, MM...

Breast Cancer Highlights From San Antonio

Breast Cancer Highlights From San Antonio

by tatyana-admore

Joyce O'Shaughnessy, MD. Kimberly Blackwell, MD. ...

Managing Breast Cancer in the Genomic Era

Managing Breast Cancer in the Genomic Era

by alida-meadow

Leisha. A. . Emens. , M.D., . Ph.D. Associate Pr...

New Therapies for Metastatic Breast Cancer

New Therapies for Metastatic Breast Cancer

by alexa-scheidler

Sigrun Hallmeyer, MD. Oncology Specialists, SC. D...